483 Novartis Pharmaceuticals A. G. Mar 2017

483 Novartis Pharmaceuticals A. G. Mar 2017

Jamie Dion FDA, Tenzin Jangchup FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals A. G. - Broomfield, CO, United States facility and issued inspectional observations (via FDA 483) on 23 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Mar 2017
  • Location: Broomfield, United States
  • FEI: 3013367255
Add To Cart